par Braga, S;Dal Lago, Lissandra 
;Bernard, Chantal ;Cardoso, Fatima ;Piccart-Gebhart, Martine
Référence Expert review of anticancer therapy, 6, 8, page (1153-1164)
Publication Publié, 2006-08
;Bernard, Chantal ;Cardoso, Fatima ;Piccart-Gebhart, Martine Référence Expert review of anticancer therapy, 6, 8, page (1153-1164)
Publication Publié, 2006-08
Article révisé par les pairs
| Titre: |
|
| Auteur: | Braga, S; Dal Lago, Lissandra; Bernard, Chantal; Cardoso, Fatima; Piccart-Gebhart, Martine |
| Informations sur la publication: | Expert review of anticancer therapy, 6, 8, page (1153-1164) |
| Statut de publication: | Publié, 2006-08 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| Mots-clés: | Adjuvant treatment |
| Cardiotoxicity | |
| Early breast cancer | |
| HER-2 | |
| Trastuzumab | |
| MeSH keywords: | Antibodies, Monoclonal -- therapeutic use |
| Antineoplastic Agents -- therapeutic use | |
| Breast Neoplasms -- drug therapy | |
| Breast Neoplasms -- mortality | |
| Breast Neoplasms -- pathology | |
| Female | |
| Humans | |
| In Situ Hybridization, Fluorescence | |
| Multicenter Studies as Topic | |
| Neoplasm Staging | |
| Randomized Controlled Trials as Topic | |
| Receptor, erbB-2 -- genetics | |
| Receptor, erbB-2 -- immunology | |
| Recurrence | |
| Note générale: | Journal Article |
| Review | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:1473-7140 |
| info:doi/10.1586/14737140.6.8.1153 | |
| info:scp/33748115504 | |
| info:pmid/16925482 |
